Musk’s Latest: Advanced Technology Restores Sight for the Blind

Neuralink, a company owned by Elon Musk, has announced the introduction of a new technology that could bring a major breakthrough in treating blindness through an advanced visual implant.

Following successful trials on monkeys, the implant received approval from the U.S. Food and Drug Administration (FDA), which described it as a “medical breakthrough.”

The new visual implant developed by Neuralink aims to restore vision for individuals who have lost their sight, even for those born blind.

The company emphasizes that the ability to see will gradually improve over time as the new implant adjusts to performing its natural function.

The FDA has classified the implant as an “advanced device,” reflecting its significant potential in treating life-threatening conditions.

In preparation for the next phase, Neuralink has started accepting applications from individuals interested in testing this new technology.

In a similar vein, Synchron, a competitor, had previously launched a smart chip to control technological devices through thought, highlighting ongoing advancements in the field of neural technology.